This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Narayan Swamy Panduranga: Innovator in Pharmaceutical Formulations
Introduction
Narayan Swamy Panduranga is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in enhancing the performance of amorphous solid and solubilized formulations. His work aims to achieve therapeutic plasma concentrations, which is crucial for effective medication delivery.
Latest Patents
Narayan Swamy Panduranga holds 1 patent for his invention titled "Enhanced performance of amorphous solid and solubilized formulations for achieving therapeutic plasma concentrations." This invention focuses on solid amorphous Compound (I) and its formulations, which include solid amorphous dispersions and solution formulations. These formulations are designed to exhibit enhanced stability and bioavailability, making them valuable in therapeutic applications.
Career Highlights
Narayan Swamy Panduranga is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves research and development in innovative drug formulations, contributing to advancements in the pharmaceutical industry.
Collaborations
Throughout his career, Narayan has collaborated with several professionals, including Robert J Garmise and Jaquan Kalani Levons. These collaborations have fostered a productive environment for innovation and development in pharmaceutical sciences.
Conclusion
Narayan Swamy Panduranga's contributions to pharmaceutical formulations highlight his commitment to improving drug delivery systems. His innovative work continues to impact the field positively, paving the way for future advancements in medication efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
